Delayed saccadic eye movements in glaucoma
Raageen Kanjee,1 Yeni H Yücel,1,2 Martin J Steinbach,3,4 Esther G González,3,4 Neeru Gupta1,2,5
1Ophthalmology and Vision Sciences, Laboratory Medicine and Pathobiology, St Michael's Hospital, University of Toronto, 2Keenan Research Centre at the Li Ka Shing Knowledge Institute of St Michael's Hospital, 3Toronto Western Hospital, University Health Network, 4Centre for Vision Research, York University, 5Glaucoma and Nerve Protection Unit, St Michael's Hospital, Toronto, ON, Canada
Purpose: To determine whether saccadic eye movements are altered in glaucoma patients.
Patients and methods: Sixteen patients with glaucoma and 21 control subjects were prospectively studied. Patients participated in a pro-saccade step task. Saccades were recorded using a noninvasive infrared oculometric device with head-mounted target projection. Medians of saccade reaction time, duration, amplitude, and peak velocity; frequency of express saccades; and percentage of trials with direction error were recorded. t-tests were used to compare the glaucoma and age-matched control groups. A correlation analysis of saccade parameters with visual field loss was also performed.
Results: Median saccade reaction times were significantly prolonged in glaucoma patients compared with controls (220.9 ± 49.02 ms vs 192.1 ± 31.24 ms; t-test: P = 0.036). Median duration, median amplitude, and median peak velocity of saccades did not show significant differences between glaucoma and control groups (P > 0.05). Frequency of express saccades was significantly decreased in glaucoma patients compared with controls (1.75 ± 2.32 vs 7.0 ± 6.99; t-test: P = 0.007). Saccade parameters in glaucoma patients showed no significant correlation with visual field loss.
Conclusion: Saccadic eye movements are significantly delayed in patients with early, moderate, or advanced glaucoma. Determination of median saccade reaction time may offer a novel functional test to quantify visual function in glaucoma patients. Further studies are needed to determine pathological processes implicated in delayed initiation of saccades, and to assess whether alteration of saccades affects daily activities in glaucoma patients.
Keywords: visual field, latency, visual dysfunction, brain, superior colliculus, quality of life
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]
Readers of this article also read:
Published Date: 1 September 2014
Curtis EM, Marks JL
Published Date: 24 March 2014
Elboga U, Kalender E, Yalcin H
Published Date: 19 December 2013
Pedersen DR, Goetz JE, Kurriger GL, Martin JA
Published Date: 12 February 2013
Zhai G, Aref Eshghi E
Published Date: 29 June 2012
Heaton K, Azuero A, Phillips JA, Pickens H, Reed D
Published Date: 10 May 2012
Solomon JJ, Brown KK
Published Date: 7 March 2012
Gabriel J Tobón, Alain Saraux, Valérie Devauchelle-Pensec
Published Date: 31 August 2010
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli
Published Date: 7 December 2009
The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
Published Date: 14 July 2009